FdaApplication
ANDA 061866
Identifiers
- fda_app_no: ANDA061866
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE |
| application_type | ANDA |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ANSPOR | CEPHRADINE | 250MG/5ML | FOR SUSPENSION;ORAL |
| ANSPOR | CEPHRADINE | 125MG/5ML | FOR SUSPENSION;ORAL |
2 products